bioinformatics
A version of this article was originally published February 21, 2011 in The Health Care Blog Follow comments on the original blog post mHealth – otherwise known as mobile healthcare – sounds like just what the doctor ordered to help make healthcare delivery cheaper and more effective. And since the Internet today essentially resides in […]
Read MoreDecember 13, 2010 source: Xconomy San Francisco (article published at Xconomy) Can Tibion’s Bionic Leg Rewire Stroke Victims’ Brains? by Wade Roush The conventional wisdom about stroke victims is that after about 12 months of rehabilitation aimed at restoring motor control, recovery levels off. Patients never regain more movement, never get beyond whatever plateau they’ve […]
Read MoreOctober 2010 source: Medical Device & Diagnostic Industry online The MX Q&A: Ted Driscoll, Claremont Creek Ventures Fledgling device companies can get a leg up with VC firms by developing a product that is ‘unique and protectable,’ says Tibion’s anchor investor. The cofounders of Tibion Bionic Technologies may want to send a thank-you note to […]
Read MoreNovember 1, 2010 source: Gene Security Network (download the pdf press release) REDWOOD CITY, CA – November 1, 2010 – Gene Security Network, Inc. (GSN) today announced the closing of its $12M Series C financing. The financing round was led by Sequoia Capital and included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners. GSN […]
Read MoreOctober 8, 2010 source: Wall Street Journal blogs Venture Capital Dispatch by Brian Gormley “Stroke patients striving to walk normally may get a lift from a bionic leg developed by venture-backed Tibion Corp. Many stroke survivors have weakness on one side that impairs their gait. Tibion’s device, worn around the leg during physical therapy, supplies the […]
Read MoreClaremont Creek Ventures is a Gold sponsor of Personalized Medicine World Conference 2010 in Israel, 6/21-6/23. For details on the conference see: http://bit.ly/PMWCIsrael
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.